高级检索
当前位置: 首页 > 详情页

Qingre Quyu Granule stabilizes plaques through inhibiting the expression of tenascin-C in patients with severe carotid stenosis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CSCD-C

单位: [1]Beijing Univ Chinese Med, Beijing 100029, Peoples R China [2]Fushun Hosp Tradit Chinese Med, Fushun 113006, Liaoning Provin, Peoples R China [3]China Japan Friendship Hosp, Dept Natl Integrat Med, Ctr Cardiovasc Dis, Beijing 100029, Peoples R China [4]China Japan Friendship Hosp, Clin Res Inst, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: vulnerable atherosclerotic plaque CD40L matrix metalloprotease-9 tenascin-C Chinese medicine Qingre Quyue Granule

摘要:
To investigate the therapeutic effects of Qingre Quyu Granule (ae...c integral cyen > c similar to Euroe cent uc(2)', QQG) on the patients with severe carotid stenosis, and to explore the mechanism of it. Ninety-six patients with severe carotid stenosis were enrolled in the study and were classified into a QQG group (n=48) and a control group (n=48) randomly using consecutively numbered envelopes. The patients in the QQG group were given QQG and Western medicine, those in the control group were given Western medicine merely, the course of treatment was 16 weeks. All patients went through endarterectomy after treatment. Plaques were subjected to the analysis of CD3, CD68, soluble intercellular adhesion molecule 1 (ICAM-1), matrix metalloprotease-9 (MMP-9), CD40L, tenascin-C, and collagen content lipid content by immunohistochemistry or polarized light analysis. By the end of experiment, the expressions of CD3, CD68, ICAM-1, MMP9, CD40L and tenascin-C on the plaques were statistically significant lower in the QQG group compared with the control group(P < 0.01). The lipid content of the plaque was also significantly lower in the QQG group compared with the control group (P < 0.01). The interstitial collagen in the tissue sections of the plaques was also significantly higher in the QQG group in comparison with the control group (P < 0.01). QQG could stabilize carotid artery plaques through inhibiting pro-inflammation factors and restraining the tenascin-C and MMP9 pathway.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 全科医学与补充医学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 全科医学与补充医学
JCR分区:
出版当年[2013]版:
Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE
最新[2023]版:
Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2013版] 出版当年五年平均[2009-2013] 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者单位: [1]Beijing Univ Chinese Med, Beijing 100029, Peoples R China [2]Fushun Hosp Tradit Chinese Med, Fushun 113006, Liaoning Provin, Peoples R China
通讯作者:
通讯机构: [1]Beijing Univ Chinese Med, Beijing 100029, Peoples R China [3]China Japan Friendship Hosp, Dept Natl Integrat Med, Ctr Cardiovasc Dis, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)